Lack Of Survival Benefit of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Revascularized Coronary Artery Disease Patients Without History of Myocardial Infarction

被引：0
|
作者：
Nishino, Tomohiro [1 ]
Furukawa, Yutaka [1 ]
Ehara, Natsuhiko [1 ]
Kaji, Shuichiro [1 ]
Kinoshita, Makoto [1 ]
Kim, Kitae [1 ]
Kitai, Takeshi [1 ]
Yamamuro, Atsushi [1 ]
Kobori, Atsushi [1 ]
Tani, Tomoko [1 ]
Morimoto, Takeshi [2 ]
Kita, Toru [1 ]
Kimura, Takeshi [3 ]
机构：
[1] Gen Hosp, Kobe City Med Cntr, Kobe, Hyogo, Japan
[2] Kyoto Univ, Grad Sch Med, Cntr Med Educ, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan
来源：
CIRCULATION | 2011年 / 124卷 / 21期
关键词：
ACE inhibitor; Outcomes; Myocardial revascularization; Coronary heart disease; Cardioprotective drugs;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10587
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Tolerability of Angiotensin-Receptor Blockers in Patients with Intolerance to Angiotensin-Converting Enzyme Inhibitors
    Caldeira, Daniel
    David, Claudio
    Sampaio, Cristina
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (04) : 263 - 277
  • [32] Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease
    Kolesnyk, I.
    Struijk, D. G.
    Dekker, F. W.
    Krediet, R. T.
    NETHERLANDS JOURNAL OF MEDICINE, 2010, 68 (01): : 15 - 23
  • [33] Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019 Friend or Foe?
    Shyh, Grace I.
    Nawarskas, James J.
    Cheng-Lai, Angela
    CARDIOLOGY IN REVIEW, 2020, 28 (04) : 213 - 216
  • [34] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
    Mc Menamin, Una C.
    Murray, Liam J.
    Cantwell, Marie M.
    Hughes, Carmel M.
    CANCER CAUSES & CONTROL, 2012, 23 (02) : 221 - 230
  • [35] Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review
    Úna C. Mc Menamin
    Liam J. Murray
    Marie M. Cantwell
    Carmel M. Hughes
    Cancer Causes & Control, 2012, 23 : 221 - 230
  • [36] Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis
    Escobar, Johao
    Rawat, Anurag
    Maradiaga, Fabricio
    Isaak, Abraham K.
    Zainab, Sana
    Dari, Mohammedsefa Arusi
    Gdey, Martha Mekonen
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [37] Use of angiotensin-converting enzyme inhibitors in patients with diabetes and coronary artery disease
    Dell'Italia, LJ
    Rocic, P
    Lucchesi, PA
    CURRENT PROBLEMS IN CARDIOLOGY, 2002, 27 (01) : 6 - 36
  • [38] Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease
    Ferrari, R
    Ceconi, C
    Curello, S
    Pepi, P
    Mazzoletti, A
    Visioli, O
    CARDIOVASCULAR DRUGS AND THERAPY, 1996, 10 : 639 - 647
  • [39] Chronic kidney disease - Tipping the scale to the benefit of angiotensin-converting enzyme inhibitors in patients with coronary artery disease
    McCullough, Peter A.
    CIRCULATION, 2006, 114 (01) : 6 - 7
  • [40] Lack of association between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and pain improvement in patients with oral cancer
    Du, Kim N.
    Shepherd, Andrew J.
    Ma, Irvin M.
    Roldan, Carlos J.
    Amit, Moran
    Fang, Lei
    Desai, Shubh
    Cata, Juan P.
    ECANCERMEDICALSCIENCE, 2020, 14
12345